Literature DB >> 15781213

Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin.

A J Olaharski1, S T Mondrala, D A Eastmond.   

Abstract

The plant flavonol fisetin is a common dietary component that has a variety of established biological effects, one of which is the inhibition of the enzyme DNA topoisomerase II (topo II). Compounds that inhibit topo II can exert genotoxic effects such as DNA double strand breaks, which can lead to the induction of kinetochore- or CREST-negative micronuclei. Despite reports that fisetin is an effective topoisomerase II inhibitor, its genotoxic effects have not yet been well characterized. Genotoxicity testing of fisetin was conducted in TK6 and HL60 cell lines and the cells were analyzed for malsegregating chromosomes as well as for the induction of micronuclei. Using the cytokinesis-blocked CREST micronucleus assay to discriminate between micronuclei formed from chromosomal breakage (CREST-negative) and chromosomal loss (CREST-positive), a statistically significant increase in CREST-positive micronuclei was seen for all doses tested in both cell lines. CREST-negative micronuclei, however, were significantly increased at the higher test concentrations in the TK6 cell line. These data indicate that at low concentrations fisetin is primarily exerting its genotoxic effects through chromosomal loss and that the induction of DNA breaks is a secondary effect occurring at higher doses. To confirm these results, the ability of fisetin to inhibit human topoisomerase II-alpha was verified in an isolated enzyme system as was its ability to interfere with chromosome segregation during the anaphase and telophase periods of the cell cycle. Fisetin was confirmed to be an effective topo II inhibitor. In addition, significant increases in the number of mis-segregating chromosomes were observed in fisetin-treated cells from both cell lines. We conclude that fisetin is an aneugen at low concentrations capable of interfering with proper chromosomal segregation and that it is also an effective topo II inhibitor, which exerts clastogenic effects at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781213     DOI: 10.1016/j.mrgentox.2005.01.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  11 in total

1.  URD12: A urea derivative with marked antitumor activities.

Authors:  Ai-Yun Wang; Yin Lu; Hai-Liang Zhu; Qing-Cai Jiao
Journal:  Oncol Lett       Date:  2011-11-08       Impact factor: 2.967

2.  Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.

Authors:  Yasmine S Touil; Johanne Seguin; Daniel Scherman; Guy G Chabot
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-11       Impact factor: 3.333

3.  Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.

Authors:  Anna-Leena Salmela; Jeroen Pouwels; Asta Varis; Anu M Kukkonen; Pauliina Toivonen; Pasi K Halonen; Merja Perälä; Olli Kallioniemi; Gary J Gorbsky; Marko J Kallio
Journal:  Carcinogenesis       Date:  2009-04-24       Impact factor: 4.944

Review 4.  Fisetin: a dietary antioxidant for health promotion.

Authors:  Naghma Khan; Deeba N Syed; Nihal Ahmad; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2012-12-18       Impact factor: 8.401

5.  Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach.

Authors:  Steven M Bryce; Derek T Bernacki; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2016-01-13       Impact factor: 3.216

6.  A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors.

Authors:  P Gollapudi; L S Hasegawa; D A Eastmond
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2014-03-26       Impact factor: 2.873

7.  Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.

Authors:  Lauren Gardner; Rohit Malik; Yoshiko Shimizu; Nicole Mullins; Wael M ElShamy
Journal:  Breast Cancer Res       Date:  2011-05-19       Impact factor: 6.466

Review 8.  Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.

Authors:  Chetan Kumar Jain; Hemanta Kumar Majumder; Susanta Roychoudhury
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

9.  The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.

Authors:  Mаhmoud Youns; Wael Abdel Halim Hegazy
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

10.  Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors.

Authors:  Andrew J Olaharski; Nina Gonzaludo; Hans Bitter; David Goldstein; Stephan Kirchner; Hirdesh Uppal; Kyle Kolaja
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.